Up to half of patients with type 2 diabetes report poor adherence to their non-insulin medications. In this ReCAP, Dr Anne Peters, director of the University of Southern California Clinical Diabetes Programs in Los Angeles, California, offers clinicians suggestions on how to get their patients to "buy in" to these treatments, many of which do not make them feel any better. Research shows that quality of life, short- and long-term clinical outcomes, and side effects are important factors in treatment adherence. Dr Peters explains that adherence may be improved if patients understand why they need to take a medication, how it might make them feel, what to do about it, and how taking it will fit into their daily pattern. She also points out that access and affordability of the medication regimen are additional factors for which patients may need support to increase treatment adherence.
--
Anne L. Peters, MD, Professor, Department of Clinical Medicine, Clinical Scholar, Keck School of Medicine of the University of Southern California; Director, USC Clinical Diabetes Programs, University of Southern California Westside Center for Diabetes, Los Angeles, California
Anne L. Peters, MD, has disclosed the following relevant financial relationships: Serve(d) as a director, officer, partner, employee, advisor, consultant, or a trustee for: Blue Circle Health; Vertex; Abbott Diabetes Care Received research grant from: Abbott Diabetes Care; Insulet Stock options from: Teladoc; Omada Health